These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22180553)

  • 21. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of sunitinib in oral suspension.
    Navid F; Christensen R; Minkin P; Stewart CF; Furman WL; Baker S
    Ann Pharmacother; 2008 Jul; 42(7):962-6. PubMed ID: 18577759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of rifabutin in two extemporaneously compounded oral liquids.
    Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
    Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of ganciclovir in extemporaneously compounded oral liquids.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
    Zhang YP; Trissel LA; Fox JL
    Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of levofloxacin in an extemporaneously compounded oral liquid.
    VandenBussche HL; Johnson CE; Fontana EM; Meram JM
    Am J Health Syst Pharm; 1999 Nov; 56(22):2316-8. PubMed ID: 10582824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability study of oral pediatric idebenone suspensions.
    Schlatter J; Bourguignon E; Majoul E; Kabiche S; Balde IB; Cisternino S; Fontan JE
    Pharm Dev Technol; 2017 Mar; 22(2):296-299. PubMed ID: 27583702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children.
    Nahata MC; Morosco RS; Brady MT
    Am J Health Syst Pharm; 2006 Feb; 63(3):254-7. PubMed ID: 16434784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.
    Fish DN; Vidaurri VA; Deeter RG
    Am J Health Syst Pharm; 1999 Oct; 56(19):1957-60. PubMed ID: 10554914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of cyclophosphamide in extemporaneous oral suspensions.
    Kennedy R; Groepper D; Tagen M; Christensen R; Navid F; Gajjar A; Stewart CF
    Ann Pharmacother; 2010 Feb; 44(2):295-301. PubMed ID: 20103616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of a pyrimethamine suspension compounded from bulk powder.
    Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
    Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.